Progresses of T-cell-engaging bispecific antibodies in treatment of solid tumors
Article in International Immunopharmacology (July 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
PIK3CA mutation as an acquired resistance driver to EGFR-TKIs in non-small cell lung cancer: Clinical challenges and opportunities
Article in Pharmacological Research (March 2024)